A new guideline recommends that statins alone or in combination with ezetimibe not be initiated in adult dialysis patients.
A majority of patients on HD have hypertension, and CVD is the leading cause of death in these patients.
This higher level of dialysis care in Canada is partly owed to substantially higher reimbursement fees for nephrologists.
Switching from intravenous to oral alfacalcidol resulted in greater PTH suppression in patients with secondary hyperparathyroidism.
The inverse association is opposite of what is observed in the general population.
Soluble ferric pyrophosphate (Triferic), an investigational drug, is delivered to hemodialysis patients via dialysate.
It also is associated with an increased likelihood of hospitalization.
Better outcomes observed with more frequent and longer dialysis sessions.
Patients found to have a 67% increased risk of coronary events or death compared with patients who did not suffer acute kidney injury.
The Canadian Society of Nephrology recommends initiation when clinical indications emerge or when the eGFR 6 mL/min/1.73 m2 or below.
USRDS data show a decrease from 116,946 cases in 2010 to 115,643 cases in 2011.
This trait in African-American hemodialysis patients was associated with a 13.2% higher dose of erythropoiesis-stimulating agents.
The adjusted rate fell 26.5% from 1996 to 2011, but remains much higher than in the general population.
New meta-analysis shows no significant increase in hemoglobin or decrease in required erythropoietin dose.
Sexual inactivity is common but not bothersome to many women, study shows.
Renal tissue could one day be created that would be functional as well as completely immunocompatible.
Hemodialysis and peritoneal dialysis patients are more likely than non-dialysis patients to suffer an ischemic or hemorrhagic stroke.
Starting dialysis after conception, not before, may improve birth rates in women with end-stage renal disease.